Related Experiment Video
Updated: Jul 30, 2025

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
Published on: November 10, 2023
The Prevalence of mRNA Related Discussions During the Post-COVID-19 Era
Dimitrios Kokkinakis1, Bastiaan Bruinsma2, Mia-Marie Hammarlin3
1University of Gothenburg and the Centre for Ageing & Health, AgeCap, Sweden.
Abstract:
Vaccinations are one of the most significant interventions to public health, but vaccine hesitancy and skepticism are raising serious concerns for a portion of the population in many countries, including Sweden. In this study, we use Swedish social media data and structural topic modeling to automatically identify mRNA-vaccine related discussion themes and gain deeper insights into how people's refusal or acceptance of the mRNA technology affects vaccine uptake. Our point of departure is a scientific study published in February 2022, which seems to once again sparked further suspicion and concern and highlight the necessity to focus on issues about the nature and trustworthiness in vaccine safety. Structural topic modelling is a statistical method that facilitates the study of topic prevalence, temporal topic evolution, and topic correlation automatically. Using such a method, our research goal is to identify the current understanding of the mechanisms on how the public perceives the mRNA vaccine in the light of new experimental findings.
More Related Videos
08:41Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
10:16Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles
Published on: August 17, 2022
Related Concept Videos
Nuclear Export of mRNA
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
mRNA Stability and Gene Expression
Regulated mRNA Transport
Leaky Scanning
Microorganisms in Medicine and Therapeutics